A cancer neuroscience-related gene model for prognosis prediction and immunotherapy response evaluation in breast cancer

This study establishes and validates a novel 12-gene cancer neuroscience-related prognostic model for breast cancer. This model not only effectively stratifies patient risk but also reveals distinct immune landscapes and predicts differential responses to immunotherapy and potential therapeutic agents. These findings offer new insights for prognostication and personalized treatment strategies in breast cancer.